ESH 2017 | Current research into pro-apoptosis medication for leukemia
The evasion of apoptosis is a hallmark of cancer, which needs to be halted in order to treat malignancies. In this video, Andrew Wei, MBBS, PhD, FRACP, FRCPA, from Alfred Hospital and Monash University, Melbourne, Australia touches upon the mechanism of apoptosis and the use of venetoclax, a drug that can benefit patients with chronic lymphocytic leukaemia. Dr Wei also discusses his research regarding pro-survival proteins in acute myeloid leukemia. This interview was recorded at the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Hematology (ESH).
Get great new content delivered to your inboxSign up